Browse the full record of transactions filed by STOKELY DAN, Chief Financial Officer. Officer active across 1 companies, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 10 reports have been logged. The latest transaction was filed on 1 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Dan Stokely is the CFO of Ampio Pharmaceuticals, Inc. He oversees all financial operations of the company, including financial planning, reporting, and compliance. In his role, Dan ensures that Ampio maintains high standards of financial integrity and transparency. His experience in finance is crucial to support Ampio's growth strategy.